Upload Avatar (500 x 500)
Wei Wang
docweiwang@ustc.edu.cn
Chinese, English
Anhui
University of Science and Technology of China
Mayo Clinic College of Medicine
  • 2016/09–2018/06 PhD in Clinical Medicine (Oncology): Shandong University
  • 2006/09–2009/06 Master's in Surgery (General Surgery): Anhui Medical University
  • 2001/09–2006/06 Bachelor's in Clinical Medicine: Anhui Medical University
  • Selected as a reserve candidate for the 13th batch of academic and technical leaders in Anhui Province
  • First batch of 'Key Talents' by Anhui Provincial Health Commission
  • Assistant leader of the 12th batch of Anhui Province 115 Industry Innovation Team
  • 2020/12–Present - The First Affiliated Hospital of USTC - Associate Chief Physician in Oncology
  • 2015/12–2020/12 - The First Affiliated Hospital of USTC - Attending Physician in Oncology
  • 2013/06–2015/12 - The First Affiliated Hospital of USTC - Resident Physician in Oncology
  • 2009/07–2013/06 - The First Affiliated Hospital of USTC - Resident Physician in General Surgery
  • Science and Technology Progress Award (2021): First Prize by Anhui Provincial Government
  • Top 100 '35 under 35' Most Promising Young Oncologists in China (2018): CSCO
  • Outstanding Young Health Volunteer in Anhui Province
  • Hospital-level 'Young Post Expert', 'Excellent Chief Resident', 'Excellent Doctor', 'Best Contribution - Individual Award', and 'Outstanding Young Technical Backbone'
Molecular mechanisms of tumor recurrence, metastasis, and tumor immune microenvironment
Application of bioinformatics analysis in clinical and basic tumor research
Observational clinical research and clinical translational research in oncology
Construction and scientific application of tumor clinical databases
  • Nanocodelivery of an NIR photothermal agent and an acid-responsive TLR7 agonist prodrug to enhance cancer photothermal immunotherapy and the abscopal effect., Chen B, Huang R, Zeng W, Wang W*, Min Y*., 2024
  • Monophosphoryl lipid A-assembled nanovaccines enhance tumor immunotherapy., Li R, Hao Y, Pan W, Wang W*, Min Y*., 2023
  • Tumor-associated mesenchymal stem cells promote hepatocellular carcinoma metastasis via a DNM3OS/KDM6B/TIAM1 axis., Wang W, Wang Q, Huang DB, Sun QK, Wu SS, Zhao YJ, Jia W, Hu DS, He YF., 2021
  • Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy., Wang W, Hao Y, Liu Y, Li R, Huang DB, Pan YY., 2021
  • The p53/miR-193a/EGFR feedback loop function as a driving force for non-small cell lung carcinoma tumorigenesis., Wang W, Shen XB, Huang DB, Yong Wang, Pan YY., 2019
  • Peroxiredoxin 4 suppresses anoikis and augments growth and metastasis of hepatocellular carcinoma cells through the β-catenin/ID2 pathway., Wang W, Shen XB, Huang DB, Jia W, Liu WB, He YF., 2019
  • 红细胞参数对胆道癌一线化疗疗效的预测作用:一项单中心回顾性研究., 王伟*,沈夏波,王刚,何义富,季楚舒,胡冰,潘跃银., 2019
Tumor Recurrence Metastasis Immune Microenvironment Molecular Mechanisms Bioinformatics Clinical Research Translational Research Tumor Databases Oncology Cancer

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.